JILL FORD: Open Payments
NPI 1285389742 · UTICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,093 in 121 payments from 17 companies in 2025. Trend: 2023 $22 · 2024 $1,721 · 2025 $3,093
Food & beverage: $3,093
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 37 | $1,040 |
| GlaxoSmithKline, LLC. | 17 | $396 |
| Regeneron Healthcare Solutions, Inc. | 11 | $270 |
| Grifols USA, LLC | 10 | $214 |
| Amgen Inc. | 12 | $209 |
| GENZYME CORPORATION | 5 | $187 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $160 |
| Actelion Pharmaceuticals US, Inc. | 2 | $155 |
| Philips North America LLC | 5 | $122 |
| Mallinckrodt Hospital Products Inc. | 3 | $98 |
Products named: FASENRA, DUPIXENT, TEZSPIRE, NUCALA, AIRSUPRA, Prolastin-C Liquid, UPTRAVI, Vest Therapy Und.
Industry payments across NY — which companies pay providers there.
